Enliven Therapeutics shares owned by RA Capital Management
Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by RA Capital Management
from 13F filings
Historical chart of RA Capital Management investment in Enliven Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enliven Therapeutics held by RA Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enliven Therapeutics by RA Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $17M | 849k | 20.06 |
| 2025-03-31 | $17M | 849k | 19.68 |
| 2024-12-31 | $19M | 849k | 22.50 |
| 2024-09-30 | $27M | 1.1M | 25.54 |
| 2024-06-30 | $50M | 2.1M | 23.37 |
| 2024-03-31 | $37M | 2.1M | 17.59 |
| 2023-12-31 | $29M | 2.1M | 13.84 |
| 2023-09-30 | $29M | 2.1M | 13.66 |
| 2023-06-30 | $43M | 2.1M | 20.41 |
| 2023-03-31 | $47M | 2.1M | 21.90 |